MG
ACHC icon

Michael Gelband’s Acadia Healthcare ACHC Stock Holding History

Michael Gelband’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Buy
29,720
+5,867
+25% +$151K 0.01% 1107
2026
Q1 		$558K Buy
+23,853
New +$432K ﹤0.01% 1162
2025
Q4 		– Sell
-99,399
Closed -$2.46M – 1479
2025
Q3 		$2.46M Buy
99,399
+67,773
+214% +$1.51M 0.03% 663
2025
Q2 		$718K Sell
31,626
-204,703
-87% -$4.85M 0.01% 1056
2025
Q1 		$7.17M Buy
+236,329
New +$9M 0.07% 301
2024
Q4 		– Sell
-403,957
Closed -$25.6M – 1448
2024
Q3 		$25.6M Buy
403,957
+267,890
+197% +$19.3M 0.16% 107
2024
Q2 		$9.19M Buy
+136,067
New +$9.5M 0.06% 268
2023
Q4 		– Sell
-20,959
Closed -$1.47M – 1404
2023
Q3 		$1.47M Sell
20,959
-14,021
-40% -$1.05M 0.01% 803
2023
Q2 		$2.79M Buy
34,980
+2,069
+6% +$150K 0.02% 681
2023
Q1 		$2.38M Sell
32,911
-22,961
-41% -$1.79M 0.02% 809
2022
Q4 		$4.6M Buy
55,872
+50,532
+946% +$4.17M 0.07% 374
2022
Q3 		$417K Sell
5,340
-17,794
-77% -$1.42M 0.01% 1429
2022
Q2 		$1.56M Buy
23,134
+8,100
+54% +$565K 0.02% 890
2022
Q1 		$985K Buy
15,034
+11,203
+292% +$651K 0.01% 1172
2021
Q4 		$233K Sell
3,831
-15,145
-80% -$903K ﹤0.01% 1761
2021
Q3 		$1.21M Buy
18,976
+11,683
+160% +$737K 0.02% 941
2021
Q2 		$458K Buy
+7,293
New +$457K 0.01% 1492
2021
Q1 		– Sell
-38,802
Closed -$1.95M – 2068
2020
Q4 		$1.95M Buy
+38,802
New +$1.55M 0.02% 550
2020
Q3 		– Sell
-36,886
Closed -$927K – 1685
2020
Q2 		$927K Buy
36,886
+18,449
+100% +$460K 0.02% 779
2020
Q1 		$338K Buy
18,437
+11,958
+185% +$342K 0.02% 612
2019
Q4 		$215K Sell
6,479
-5,449
-46% -$171K ﹤0.01% 1310
2019
Q3 		$371K Buy
+11,928
New +$363K 0.01% 791

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Michael Gelband's ACHC Position: Q2 2026 in Review

Michael Gelband increased its Acadia Healthcare (ACHC) stake by 25% in Q2 2026, buying an estimated $151K and bringing the position to 29,720 shares worth $878K. The position accounts for 0.01% of the portfolio, ranked #1107.

Michael Gelband first reported a position in ACHC in Q3 2019 and has held it in 22 quarters since. The position peaked at $25.6M in Q3 2024. 312 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Michael Gelband held 29,720 shares of Acadia Healthcare worth $878K as of Q2 2026.
  • Michael Gelband bought 5,867 Acadia Healthcare shares in Q2 2026, an estimated $151K.
  • Acadia Healthcare made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1107 holding.
  • Michael Gelband first reported a position in Acadia Healthcare in Q3 2019 and has held it in 22 quarters since.
  • Michael Gelband's Acadia Healthcare position peaked at $25.6M in Q3 2024.
  • 312 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.